Surbhi Singh: Platelet Clumps — The Culprit Behind Pseudothrombocytopenia
Surbhi Singh, Consultant Haematopathology at Agilus Diagnostics and Fortis Hospital Gurugram, shared a post on LinkedIn:
“Cellfie Of The Day
*Platelet Clumps — The Culprit Behind Pseudothrombocytopenia
*What you see:
Large platelet aggregates on the peripheral smear, often at the feathered edge or around neutrophils/monocytes.
*Why it matters:
These clumps falsely lower automated platelet counts, leading to pseudothrombocytopenia — a lab artefact, not a true thrombocytopenia.
*Mechanism:
• Most commonly EDTA-dependent platelet agglutination.
• Autoantibodies targeting GP IIb/IIIa become activated in EDTA, causing platelets to clump in vitro.
*Clues on smear:
• Platelet clumps at the tail end.
• Adequate giant platelets or normal platelet morphology.
• Normal RBC and WBC morphology unless concurrent pathology.
*What to do:
• Repeat CBC in citrate anticoagulant.
• Manual smear review to confirm.
• Report corrected platelet count from alternative tube if clumping resolves.”
Stay informed with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis